Curative Ventures
Venture capitalDallas · 1 people tracked
Also known as CURATIVE VENTURES MANAGEMENT LLC
Find your way into Curative Ventures
1 people in our graph share verified history with the Curative Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Curative Ventures backs category-defining biotech companies working on novel therapies designed to dramatically improve patient outcomes. Acting as both a capital and talent partner, the firm supports companies advancing new treatments across areas such as oncology and other therapeutic domains. Its investment activity, evidenced by companies like Instil Bio, Peloton Therapeutics, Exonics, and TCR2 Therapeutics, spans developments through IPOs and acquisitions.
Source: firm website, verified Sep 15, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 1 of 6 portfolio companiesBiotech ×1
HQs:United States×2
Investments · 6 tracked
founders shown can be your intro path
Instil Bio is a biotechnology company that identifies and acquires or licenses therapeutic candidates for development, with a strategic focus on securing additional novel drug candidates targeting diseases with significant unmet medical needs.
BiotechDallas, US
Bronson Crouch(Chief Executive Officer & Chairman of the Board)inSandeep "Steve" Laumas(Chief Financial Officer & Chief Business Officer)inNimish Shah(Director)inGwen Binder(Director)Neil Gibson(Director)George Matcham(Director)
Co-investorsVivo CapitalCPMGVenrock
ImmuneOnco Biopharmaceuticals is a Shanghai-founded clinical-stage biotech developing bispecific antibodies and Fc-fusion proteins for immuno-oncology and other diseases.
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ExonicsiTeos TherapeuticsPeloton TherapeuticsTCR2 Therapeutics
Exits · 4
1 IPOs · 3 acquisitionsInstil BioNASDAQ: TILExonicsacq. by VertexPeloton Therapeuticsacq. by MerckTCR2 Therapeuticsacq. by Adaptimmune Therapeutics plc
Portfolio news
latest coverage across their companiesiTeos Therapeutics · ad-hoc-news.de · May 21, 2026
Instil Bio · stocktitan.net · May 15, 2026
ImmuneOnco · investing.com · Jan 6, 2026
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Instil Bio | 29.7% | $20.00 | Mar 2021 | $750.6M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- How many investments has Curative Ventures made?
- Curative Ventures has 6 tracked investments, 4 of which have exited.
- What sectors does Curative Ventures focus on?
- Curative Ventures focuses on Biotech.
- Where is Curative Ventures located?
- Curative Ventures is headquartered in Dallas, US.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.